Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $24 at JPMorgan
Tweet
Share
E-mailGet Alerts BHVN Hot Sheet
Price: $14.64 -1.41%
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JPMorgan analyst Tessa Romero lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $24.00 (from $27.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Biohaven Pharma (BHVN) PT Raised to $23 at RBC Capital
- Biohaven Pharma (BHVN) PT Raised to $19 at Morgan Stanley
- Biohaven Pharma (BHVN) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
